ACTN4 and breast carcinoma: To thoroughly investigate the global effects of EA treatment and ACTN4 knockdown on breast cancer, we additionally perform a global RNA-seq for MDA-MB-231 cells treated with EA or shACTN4 using a BGISEQ-500 by the Beijing Genomic Institution (www.genomics.org.cn, BGI, Shenzhen, China).